Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05944133 · ClinicalTrials.gov registry record
Health Insurance Instability and Mortality Among Patients Receiving Bup Tx for OUD
A clinical trial of Opioid Use Disorder and Opioid Overdose, sponsored by Kaiser Permanente.
- Active
- Registry status
- 27,257
- Enrollment target
- 1
- Study location
NCT05944133: Active study of Opioid Use Disorder and Opioid Overdose, sponsored by Kaiser Permanente.
NCT05944133 is a study of Opioid Use Disorder and Opioid Overdose that is active but no longer recruiting, run by Kaiser Permanente. The registered enrollment target is 27,257 participants, above the 4,550-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (499% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05944133, a study of Opioid Use Disorder and Opioid Overdose, is active but no longer recruiting, sponsored by Kaiser Permanente.
- ACTIVE NOT RECRUITING
- Registry status
- 27,257 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this multi-site observational cohort study is to link electronic health records (EHR) with novel data sources to examine insurance instability and its association with all-cause and overdose mortality in adult patients who received medications for opioid use disorder (MOUD). The main objectives of the study are: * Objective 1. Perform data linkage of a cohort of patients who received MOUD with the National Death Index using a probabilistic algorithm for matching records to ascertain fact and cause of death relative to treatment and insurance status. * Objective 2: Assess the association of insurance instability and risk of death, including all-cause mortality and drug- and alcohol-related overdose mortality.
Primary Outcome
Death and cause-of-death data from the National Death Index (NDI) will serve as the primary data source for outcomes. Outcome will be identified across follow-up from start of treatment and up to one year after disenrollment from the health system.
Conditions Studied
Interventions
- OTHER No intervention, observational retrospective study
Study Locations (1)
Colorado
- Kaiser Permanente Colorado - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27,257 participants |
| Start Date | 2023-03-29 |
| Est. Completion | 2026-02-28 |
What the registry record for NCT05944133 still lists
NCT05944133 is an observational study that tracks outcomes without assigning an intervention. Its 27,257 participants enrollment target places it among the larger protocols in the corpus, above the 4,550-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (499% higher).
The record links to 3 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which No intervention, observational retrospective study is the first listed.
NCT05944133 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT05944133 about?
NCT05944133 is a clinical study titled "Health Insurance Instability and Mortality Among Patients Receiving Bup Tx for OUD". The goal of this multi-site observational cohort study is to link electronic health records (EHR) with novel data sources to examine insurance instability and its association with all-cause and overdose mortality in adult patients who received medications for opioid use disorder (MOUD). The main obj...
What is the current status of trial NCT05944133?
This trial is currently active not recruiting. The enrollment target is 27,257 participants. The study started on 2023-03-29. Estimated completion is 2026-02-28.
What conditions does trial NCT05944133 study?
This clinical trial studies the following conditions: Opioid Use Disorder, Opioid Overdose, Death.
What interventions are being tested in trial NCT05944133?
The interventions under investigation include: No intervention, observational retrospective study (OTHER).
Who is sponsoring clinical trial NCT05944133?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05944133 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05944133's enrollment target sits among peer trials
27,257 4th of 257 higher than 254 of 257 other Opioid Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders
RECRUITING · Phase 2
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04494945 · 27,500 participants · NA
Identifying and Caring for Individuals With Inherited Cancer Syndrome
- NCT04678193 · 27,000 participants
COVID-19 Risk Assessment for Hospitalization Outcomes and Epidemiology Efficacy
- NCT07300839 · 25,500 participants · Phase 3
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
- NCT03175302 · 25,240 participants
PREsurgical Cognitive Evaluation Via Digital clockfacEdrawing
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI